Clinical Trials Browser

Recurrence × iratumumab × Clear all

Hodgkin Disease, Recurrence

NCT00059995 2013-05-30

MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma

Hodgkin Disease, Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Dendritic Cell Sarcoma, Interdigitating

Clinical Trials

A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease

MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma